Carcinoid heart disease: Diagnosis and management

被引：31
|
作者：
Luis, Sushil A. [1 ]
Pellikka, Patricia A. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN 55905 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2016年 / 30卷 / 01期
关键词：
carcinoid; valves; Hedinger syndrome; echocardiography; ENETS CONSENSUS GUIDELINES; BRAIN NATRIURETIC PEPTIDE; CARDIAC-SURGERY; HEPATIC RESECTION; VALVULAR SURGERY; PROGRESSION; STANDARDS; PROGNOSIS; OUTCOMES; CARE;
D O I：
10.1016/j.beem.2015.09.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hedinger syndrome refers to carcinoid valvular heart disease. The disease is believed to be triggered by vasoactive substances that result in valvular fibrosis. It classically occurs in patients with metastatic carcinoid and preferentially involves the right sided cardiac valves. Affected valves become thickened and retracted, exhibiting regurgitation and sometimes, stenosis. Echocardiography is recommended in patients with carcinoid syndrome and a follow up study is advisable in those who develop a murmur or other symptoms or signs of valvular heart disease. For appropriately selected patients, valve replacement surgery appears to improve outcomes. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：149 / 158
页数：10
相关论文
共 50 条
  • [1] The clinical presentation and management of carcinoid heart disease
    Dobson, R.
    Burgess, M. I.
    Pritchard, D. M.
    Cuthbertson, D. J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (01) : 29 - 32
  • [2] Carcinoid Heart Disease - A Review of Pathophysiology, Clinical Manifestations, Diagnosis and Management
    Ghanta, Sai Nikhila
    Vallurupalli, Srikanth
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2023, 8 (01)
  • [3] Multidisciplinary team management of carcinoid heart disease
    Steeds, Richard P.
    Sagar, Vandana
    Shetty, Shishir
    Oelofse, Tessa
    Singh, Harjot
    Ahmad, Raheel
    Bradley, Elizabeth
    Moore, Rachel
    Vickrage, Suzanne
    Smith, Stacey
    Yim, Ivan
    Elhassan, Yasir S.
    Venkataraman, Hema
    Ayuk, John
    Rooney, Stephen
    Shah, Tahir
    ENDOCRINE CONNECTIONS, 2019, 8 (12) : R184 - R199
  • [4] Carcinoid heart disease
    Hassan, Saamir A.
    Banchs, Jose
    Iliescu, Cezar
    Dasari, Arvind
    Lopez-Mattei, Juan
    Yusuf, Syed Wamique
    HEART, 2017, 103 (19) : 1488 - 1495
  • [5] A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease
    Namkoong, Jenny
    Andraweera, Prabha H.
    Pathirana, Maleesa
    Munawar, Dian
    Downie, Michael
    Edwards, Suzanne
    Averbuj, Paula
    Arstall, Margaret A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [6] The Past, Present, and The Future of Carcinoid Heart Disease
    Meir, Juliet
    Michaud, Liana
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2023, 31 (04) : 193 - 198
  • [7] Managing carcinoid heart disease in patients with neuroendocrine tumors
    Koffas, Apostolos
    Toumpanakis, Christos
    ANNALES D ENDOCRINOLOGIE, 2021, 82 (3-4) : 187 - 192
  • [8] Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland
    Dobson, R.
    Valle, J. W.
    Burgess, M. I.
    Poston, G. J.
    Cuthbertson, D. J.
    CLINICAL ONCOLOGY, 2015, 27 (12) : 741 - 746
  • [9] Current Concepts in Diagnosis and Perioperative Management of Carcinoid Heart Disease
    Castillo, Javier G.
    Silvay, George
    Solis, Jorge
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2013, 17 (03) : 212 - 223
  • [10] Carcinoid heart disease: a guide for screening and timing of surgical intervention
    Hart, E. A.
    Meijs, T. A.
    Meijer, R. C. A.
    Dreijerink, K. M.
    Tesselaar, M. E.
    de Groot, C. A.
    Valk, G. D.
    Chamuleau, S. A. J.
    NETHERLANDS HEART JOURNAL, 2017, 25 (09) : 471 - 478
12345